Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV005259083 | SCV005925452 | uncertain significance | Inborn genetic diseases | 2025-01-20 | criteria provided, single submitter | clinical testing | The c.179A>C (p.H60P) alteration is located in exon 3 (coding exon 3) of the PTS gene. This alteration results from a A to C substitution at nucleotide position 179, causing the histidine (H) at amino acid position 60 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |